|
Volumn 22, Issue 3, 2011, Pages 448-455
|
A novel dose regimen of cinacalcet in the treatment of severe hyperparathyroidism in hemodialysis patients.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKALINE PHOSPHATASE;
CALCIUM;
CINACALCET;
NAPHTHALENE DERIVATIVE;
PARATHYROID HORMONE;
ADULT;
AGED;
ARTICLE;
BLOOD;
CHI SQUARE DISTRIBUTION;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HYPERPARATHYROIDISM;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RENAL REPLACEMENT THERAPY;
ADULT;
AGED;
ALKALINE PHOSPHATASE;
CALCIUM;
CHI-SQUARE DISTRIBUTION;
FEMALE;
HUMANS;
HYPERPARATHYROIDISM;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
NAPHTHALENES;
PARATHYROID HORMONE;
PROSPECTIVE STUDIES;
RENAL DIALYSIS;
|
EID: 79961147015
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|